Search Results - "Farina, Antonietta Rosella"
-
1
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
Published in Journal of experimental & clinical cancer research (15-06-2020)“…Hypoxia-induced alternative splicing is a potent driving force in tumour pathogenesis and progression. In this review, we update currents concepts of…”
Get full text
Journal Article -
2
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells
Published in International journal of molecular sciences (17-09-2022)“…Patients with advanced neuroblastoma (NB) receive multimodal clinical therapy, including the potent anthracycline chemotherapy drug doxorubicin (Dox). The…”
Get full text
Journal Article -
3
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells
Published in International journal of molecular sciences (17-05-2024)“…Pediatric neuroblastomas (NBs) are heterogeneous, aggressive, therapy-resistant embryonal tumors that originate from cells of neural crest origin committed to…”
Get full text
Journal Article -
4
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma
Published in Journal of experimental & clinical cancer research (05-12-2019)“…Identification of novel cancer-associated splice variants is of potential diagnostic, prognostic and therapeutic importance. NF-Y transcription factor is…”
Get full text
Journal Article -
5
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII
Published in Journal of experimental & clinical cancer research (18-06-2018)“…Oncogenes derived from the neurotrophin receptor tropomyosin-related kinase TrkA act as drivers in sub-populations of a wide-range of human cancers. This,…”
Get full text
Journal Article -
6
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A
Published in International journal of molecular sciences (03-11-2020)“…Merkel cell carcinomas (MCCs) are rare, aggressive, cutaneous neuroendocrine tumours, approximately 80% of which are caused by the genomic integration of…”
Get full text
Journal Article -
7
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target
Published in Journal of experimental & clinical cancer research (22-10-2019)“…Merkel cell carcinomas (MCCs) are rare, aggressive, therapeutically-challenging skin tumours that are increasing in incidence and have poor survival rates. The…”
Get full text
Journal Article -
8
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood
Published in Life (Basel, Switzerland) (01-11-2022)“…Neuroblastoma (NB) is a highly malignant embryonic extracranial solid tumor that arises from sympathoadrenal neuroblasts of neural crest origin. In addition to…”
Get full text
Journal Article -
9
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression
Published in Biology (Basel, Switzerland) (01-03-2024)“…Pituitary neuroendocrine tumors (PitNETs) are generally benign but comprise an aggressive, invasive, therapy-resistant, metastatic subset, underpinning a need…”
Get full text
Journal Article -
10
The Alternative TrkAIII Splice Variant Targets the Centrosome and Promotes Genetic Instability
Published in Molecular and Cellular Biology (01-09-2009)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
11
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
Published in Cancers (27-01-2014)“…Since its original identification as a leukocyte gelatinase/type V collagenase and tumour type IV collagenase, gelatinase B/matrix metalloproteinase (MMP)-9 is…”
Get full text
Journal Article Book Review -
12
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced Wild-Type BRAF Melanoma Patients
Published in The Journal of surgical research (01-12-2021)“…•Treatment strategies for advanced cutaneous melanoma patients, ineligible for novel target and immunotherapies, remain a challenge.•In a BRAF wild-type…”
Get full text
Journal Article -
13
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation
Published in Oncotarget (02-02-2018)“…Alternative TrkAIII splicing characterises advanced stage metastatic disease and post-therapeutic relapse in neuroblastoma (NB), and in NB models TrkAIII…”
Get full text
Journal Article -
14
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting
Published in World journal of stem cells (26-07-2021)“…Pediatric neuroblastomas (NBs) are heterogeneous, aggressive, therapy-resistant embryonal tumours that originate from cells of neural crest (NC) origin and in…”
Get full text
Journal Article -
15
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity
Published in Oncotarget (03-11-2015)“…In human SH-SY5Y neuroblastoma (NB) cells, nascent immature N-glycosylated 110kDa TrkA moves rapidly from the endoplasmic reticulum (ER) to the Golgi Network…”
Get full text
Journal Article -
16
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma
Published in Oncotarget (06-12-2016)“…TrkAIII expression in neuroblastoma (NB) associates with advanced stage disease, worse prognosis, post therapeutic relapse, and in NB models TrkAIII exhibits…”
Get full text
Journal Article -
17
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site
Published in Experimental cell research (10-06-2003)“…Advanced stage neuroblastomas (NB) exhibit a tissue inhibitor of metalloproteinase (TIMP)-2/matrix metalloproteinase (MMP) imbalance, considered a prerequisite…”
Get full text
Journal Article -
18
Prostaglandin E2Inhibits the Interleukin-2 Promoter Activity through Down-Regulation of the Oct-Dependent Transcription of the Octamer Motif
Published in Cellular immunology (15-09-1996)“…Prostaglandins, mainly those of the E series (PGE), are modulators of immune responses. Indeed PGE2inhibits T cell activation and the transcription of the…”
Get full text
Journal Article -
19
Prostaglandin E2 inhibits the interleukin-2 promoter activity through down-regulation of the Oct-dependent transcription of the octamer motif
Published in Cellular immunology (15-09-1996)“…Prostaglandins, mainly those of the E series (PGE), are modulators of immune responses. Indeed PGE2 inhibits T cell activation and the transcription of the…”
Get full text
Journal Article